Biotechnology Institute

Leader in Regenerative Medicine and Oral Implantology

Synca is proud to announce its exclusive partnership with BTI® Biotechnology Institute in Canada. BTI® Biotechnology Institute is a Spanish multinational company specialising in biomedicine and biotechnology whose activity focuses on two areas: Regenerative Medicine and Oral Implantology.

BTI® is carrying out research since 1995 & regarded worldwide as a scientific pioneer in Regenerative Medicine for the development and patents of the technology of plasma rich in growth factors Endoret® (prgf®) in different fields of medicine. In the area of Oral Implantology, BTI® developed an Implant System which stands out internationally for its quality, innovation and versatility.

BTI's Implants & Abutments

BTI designs and manufactures the most versatile dental implant system on the market, a system that adapts to all bone conditions of the patient. BTI has developed the UnicCa® surface, chemically modified with calcium ions to improve osseointegration.

Regenerative Medecine (Endoret PRGF)

BTI is a scientific world leader in regenerative medicine for the development and patenting of Plasma Rich in Growth Factors (ENDORET® PRGF®) technology and its various appli-cations in multiple fields of medicine such as oral and maxillo- facial surgery, traumatology, dermatology, rheumatology, ophthalmology, sports medicine and cosmetic medicine.

Training & Research

  • More than 5000 m2 devoted to training, clinical
  • practice and research
  • More than 40 scientific collaboration agreements with universities and research institutes all over the world
  • More than 1200 students per year
  • Collaboration with experts from different countries in different fields of medicine for the development of clinically effective protocols
  • More than 150 indexed scientific publications back the effectiveness and biosafety of ENDORET® PRGF®
  • 20% of the workforce dedicated to research
  • More than 20 years of research in tissue regeneration